Lessons Learned through Research: Do Hospitals and Ambulatory Centers Follow Guideline Recommended Care Nancy Albert, PhD, RN, CCNS, CCRN, NE-BC, FAHA,
Post AHA 13: lo mejor en insuficiencia cardiaca
Las asistencias circulatorias implantables ya están aquí
Matters of the Heart 2014
THE PROFILE OF THE HEART FAILURE PATIENT WHO DOESN’T BENEFIT FROM AN ICD Giosuè Mascioli, MD, FESC Humanitas Gavazzeni - Bergamo.
Are LVADs Ready To Be Mainstream? Joseph G. Rogers, MD Associate Professor of Medicine Duke University Medical Center J105-0311.
Are we ready to implant LVAD’s in the less sick? Ileana L. Piña, MD, MPH Professor of Medicine and Epi/Pop Health Albert Einstein College of Medicine Associate.
Evolving Patterns Of Use Of Aldosterone Inhibition In Chronic Heart Failure; A Report From Get With The Guidelines HF Nancy M. Albert, Clyde W. Yancy,
Cardiac Resynchronization Therapy (CRT) Is an Effective Treatment for Heart Failure and Indications Are Expanding Multiple trials have shown the clinical.
Amber E. Johnson, MD, MBA PGY-3 Johns Hopkins Bayview Medical Center Amber E. Johnson, MD, MBA PGY-3 Johns Hopkins Bayview Medical Center The Impact of.
Presenting Choices to Patients Larry Allen, MD INTERMACS May 16, 2015.
Heart Transplant: Still the Most Cost Effective and Durable Treatment for Advanced Heart Failure Arsalan Shirwany, MD Stern Cardiovascular Foundation Baptist.